Designing and repurposing drugs to target intrinsically disordered proteins for cancer treatment: using NUPR1 as a paradigm
Authors | Santofimia-Castaño P, Rizzuti B, Xia Y, Abian O,,,,, Peng L, Velázquez-Campoy A,,,,, Iovanna JL, Neira JL, |
---|---|
Details | Mol Cell Oncol. 2019 May 16;6(5):e1612678. doi: 10.1080/23723556.2019.1612678. eCollection 2019 |
DOI | 10.1080/23723556.2019.1612678 |
Topics | |
Keywords | |
Source | View on PubMed |
Join the conversation